Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug hol...
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
About this item
Full title
Author / Creator
Publisher
Milan: Springer Milan
Journal title
Language
English
Formats
Publication information
Publisher
Milan: Springer Milan
Subjects
More information
Scope and Contents
Contents
Background
Migraine frequency increases after the cessation of successful preventive treatment with CGRP(-receptor) monoclonal antibodies (mAbs). In this study, we aimed to evaluate the course of migraine after treatment resumption.
Methods
Patients with migraine, who started treatment with the same CGRP(-R) mAb after a three-month drug ho...
Alternative Titles
Full title
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6408262051194c7cb22c4fc01a683060
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6408262051194c7cb22c4fc01a683060
Other Identifiers
ISSN
1129-2369
E-ISSN
1129-2377
DOI
10.1186/s10194-022-01417-9
